The utility of ESR, CRP and platelets in the diagnosis of GCA

Abstract

Background To compare the utility of ESR, CRP and platelets for the diagnosis of GCA. Method A clinical diagnosis of GCA was determined by case-note review of 270 individuals (68% female, mean age 72 years) referred to a central pathology service for a temporal artery biopsy between 2011 and 2014. The highest levels of ESR, CRP and platelets (within 2 weeks of diagnosis) were documented. Evaluation of ESR, CRP and platelets for the diagnosis of GCA were compared using Receiver Operating Characteristic Area Under the Curve (ROC-AUC), and sensitivity/specificity at optimum cut-off values. Results GCA was clinically diagnosed in 139 (67%) patients, with 81 TAB positive. The AUC estimates for ESR, CRP and platelets were comparable (0.65 vs 0.72 vs 0.72, p = 0.08). The estimated optimal cut-off levels were confirmed at 50 mm/hour for ESR, and determined as 20 mg/L for CRP and 300 × 10 9 /L for platelets. Sensitivity estimates for these three tests were comparable ( p = 0.45) and ranged between 66% for ESR and 71% for platelets. Specificity estimates were also comparable ( p = 0.11) and ranged between 57% for ESR and 68% for CRP. There was only moderate agreement between the three positive tests (agreement 67%, kappa: 0.34), and when considered collectively, CRP and platelet positive tests were independent predictors of GCA ( p < 0.001), but the ESR was not ( p = 0.76). Conclusion ESR, CRP and platelets are moderate, equivalent diagnostic tests for GCA, but may yield disparate results in individual patients. A combination of CRP and platelet tests may provide the best diagnostic utility for GCA.

One Giant Step for Giant Cell Arteritis: Updates in Diagnosis and Treatment

“…Thus, while elevated inflammatory markers are important, their absence does not rule out the disease. The sensitivities of ESR 9 50 mm/h, CRP 9 20 mg/L, and platelets 9 300 × 10 9 /L were 65.5%, 66.9%, and 71.2% respectively, while specificities were 57.3%, 67.9%, and 71.2% respectively in one study of 139 patients, when compared against physician-determined diagnosis [41]. In the same analysis, if just ESR and CRP were positive, with normal platelets, the odds ratio of GCA was 4.0, which increased to 10.7 if platelets were high as well.…”

Aptamers for Proteins Associated with Rheumatic Diseases: Progress, Challenges, and Prospects of Diagnostic and Therapeutic Applications

“…Elevated CRP levels can be revealed before the clinical manifestation of inflammatory arthropathy [ 50 ]. The evaluation of the activity of systemic vasculitis are also based on the measurement of CRP levels [ 51 , 52 ]. An increased CRP level may be a predictive marker of systemic scleroderma progression for both skin lesions and pulmonary fibrosis [ 53 , 54 ].…”

Giant Cell Arteritis: Current Advances in Pathogenesis and Treatment

“…Platelets are also considered a serum marker for inflammation in GCA. The postulated mechanism of thrombocytosis in promoting inflammation stems from their early interaction with the endothelium in inflammatory states during which they provide adhesion molecules and chemotactic stimulation to aid in the recruitment of leukocytes and enhance the release of different inflammatory mediators [10].…”